ATTENTION: ACTIVE INVESTORS

Market Metrics & Moves Playbook

Issue: "Tech & Biotech Breakouts: AI Infrastructure to Genomic Innovation Leaders"

NEXT 7 DAYS EARNINGS PREVIEW

Editor's Note: As the high-stakes February 26 earnings report approaches, market watchers are focused intently on Nvidia's trajectory. The company's historic rise to a $3 trillion valuation has set unprecedented expectations. Key focus areas include AI chip demand sustainability, data center spending trends, and potential regulatory headwinds. Our analysis indicates this earnings release could significantly impact the broader AI and semiconductor sectors.

css Copy

A trusted partner has just released time-sensitive research that I believe warrants your immediate attention.

Nvidia's "Silent Partners" have Feb. 26 circled in red

Nvidia's Next Big Move Comes on Feb. 26

Inside the crucial data that could reshape tech investing in 2025.

Watch Now >>
Three emerging biotechnology and consumer stocks are set to report earnings on February 27, 2025. These companies, including Zai Lab (ZLAB), Cardiff Oncology (CRDF), and Barfresh Food Group (BRFH), have shown significant momentum with yearly gains ranging from 65% to 245%. Each company represents different market segments and growth opportunities, from China's healthcare market to cancer therapeutics and ready-to-blend beverages.

1 ZAI LAB LIMITED (ZLAB) - Reports Feb 27, Before Market

Chinese biopharmaceutical company focused on cancer and autoimmune disease treatments, showing strong momentum with 65% yearly gain. Trading at $33.91, the company has established a significant presence in the Chinese healthcare market. Analysts maintain unanimous buy ratings with average price target of $47.80, suggesting 41% upside potential despite current market volatility.

Key Metrics:

• Market Cap: $3.80B
• PE Ratio: -12.11
• YTD Change: 28.11%
• Revenue: $355.75M
• Operating Income: -$327.57M
• Net Income: -$270.85M

Editor's Note: 

This presentation just crossed my desk from one of our most trusted partners, and I have to say - it's a must-watch.

Money & Markets Exclusive Event

Why the World's Largest AI Company Could Unleash Pandemonium...

In the Stock Market, and Throw Trump's Second Term into Utter Chaos...

All ahead of May 21st, 2024.

These aren't normal business moves we normally see from Big Tech...

They're emergency measures.

And I suspect it's because they know what's coming next.

A critical flaw in the AI revolution...

One that could throw Trump's entire tech agenda into chaos.

The mainstream media still hasn't connected the dots...

But Wall Street insiders have already started positioning themselves.

2 CARDIFF ONCOLOGY INC (CRDF) - Reports Feb 27, After Market

Clinical-stage biotech company developing cancer treatments with focus on onvansertib. Stock has surged 147% over past year with analysts projecting 160% upside to $11 target. Recent positive trial data and strong institutional backing have driven momentum, though pre-revenue status presents development risks.

Key Metrics:

• Market Cap: $281.37M
• PE Ratio: -4.45
• YTD Change: -2.53%
• Revenue: $689K
• Operating Income: -$46.41M
• Net Income: -$43.01M

3 BARFRESH FOOD GROUP INC (BRFH) - Reports Feb 27, After Market

Ready-to-blend beverage manufacturer targeting restaurant chains, showing impressive 245% yearly gain. Small-cap growth story with expanding distribution network and strong revenue trajectory. Limited analyst coverage but positive ratings suggest 30% upside potential, though small market cap makes stock volatile.

Key Metrics:

• Market Cap: $63.87M
• PE Ratio: -22.44
• YTD Change: N/A
• Revenue: $9.85M
• Operating Income: -$2.66M
• Net Income: -$2.67M

If this article makes sense,
YOU NEED TO WATCH THIS BELOW...

looking for opportunities?

YOU NEED TO CLICK BELOW...

Nvidia's Next Big Move Comes on Feb. 26

Nvidia's "Silent Partners" have Feb. 26 circled in red

Nvidia continues to lead the pack when it comes to AI…

Following a year when the AI chip giant became just the third company ever with a market cap greater than $3 trillion…

There are no signs of slowing down in 2025.

Wednesday, Feb. 26 is the next key date for Nvidia.

That is when its latest quarterly earnings call takes place.

And get this, the last time Nvidia had this call, in November…

It announced year-over-year gains in one key AI sector of 112%.

Now, with Nvidia already dominating AI's newest frontier ...

A move that was recently valued at more than $1 trillion…

The Feb. 26 call could skyrocket Nvidia's stock even further.

And Nvidia isn't the only company eagerly awaiting this call…

You see, companies partnering with Nvidia on this AI journey have already seen their own stocks soar.

Chart

Companies like ASML, up as much as 500%…

Chart

SMCI, up as much as 3,244%…

Chart

And TSM, up as much as 6,583%.

Now, with Nvidia's recent move to this $1 trillion Superproject…

On Feb. 26, a small handful of Nvidia's other partners could see their own stocks surge upward.

YES, I WANT TO WATCH THIS NOW >>

Newsletter Content

Former pit trader exposes "824% pattern"

Government reports are creating predictable moves...

The numbers don't lie. Market moves are 824% larger on specific, predictable days. A former pit trader has broken down exactly why this is happening...

EXPOSED: Wall Street's true crypto agenda

Wall Street's new crypto playbook leaked...

This wasn't supposed to get out. Major financial institutions are executing a carefully planned crypto strategy - and it's nothing like previous cycles...

The AI war just turned real

Market veteran issues urgent AI warning...

Meta: billion AI investment. Tesla: 8% revenue drop. Chinese AI: Major breakthrough. Fed: Changed inflation outlook. These four events happened within 24 hours...

Disclaimer

Market Movers Playbook, a brand under Market Insiders Media dba, operates under the parent company Sandpiper Marketing Group, LLC. Please be advised that Market Movers Playbook is not registered as an investment adviser or broker-dealer with the United States Securities and Exchange Commission or any state regulatory agency. We rely on the "publisher's exclusion" from the definition of investment adviser as set forth in Section 202(a)(11) of the Investment Advisers Act of 1940, as amended, as well as corresponding state securities laws. Consequently, Market Movers Playbook does not offer or provide personalized investment advice. The information we provide is based on our opinions, statistical and financial data, and independent research of public information. Our materials are intended for informational purposes only, and no mention of a specific security in any of our content constitutes a recommendation to buy, sell, or hold that or any other security. Any information deemed to be investment opinion is impersonal and not tailored to the investment needs of any individual. Please be aware that Market Movers Playbook does not promise, guarantee, or imply that any information provided through our websites, newsletters, reports, or printed material will result in profit or loss. We strongly encourage you to seek personal advice from your professional investment, tax, or legal advisors and to conduct your own due diligence and independent investigations before acting on any information we publish or making any investment decision. Only you and your professional advisors can determine the level of risk appropriate for you. Penny stocks, in particular, are inherently speculative investments, and you should be prepared to lose your entire investment. Employees, owners, and/or writers of Market Movers Playbook may own positions in the equities, options, and/or securities mentioned in our content. However, no associated employees will intentionally engage in any transaction that directly or indirectly competes with the interests of our subscribers. Market Movers Playbook may be compensated for publishing information about companies referred to in our reports, newsletters, and websites, and we provide full disclosure of such compensation. Furthermore, please note that any content marked as "Sponsor" may be paid for and is not endorsed or warranted by our staff or company. The content in our emails is for educational or entertainment use and is not a substitute for professional advice or an offer to buy or sell any securities. Neither the publisher nor the editors are registered investment advisors (RIA's) and do not provide personalized counseling. Be sure to conduct your own careful research and consult with your advisors before taking any action based on our content. By opening our emails or clicking any links contained therein, you are reconfirming your opt-in status, which is part of your free subscription.